INC Research Holdings Company Profile (NASDAQ:INCR)

About INC Research Holdings (NASDAQ:INCR)

INC Research Holdings logoINC Research Holdings, Inc. is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services. The Company's Clinical Development Services segment offers a range of clinical development services, including full-service global studies, as well as ancillary services, such as clinical monitoring, investigator recruitment, patient recruitment, data management, study reports to assist customers with their drug development process, quality assurance audits and specialized consulting services. The Phase I Services segment focuses on clinical development services for Phase I trials, which include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology & Medical Research
  • Sub-Industry: N/A
  • Symbol: NASDAQ:INCR
  • CUSIP: N/A
  • Web:
  • Market Cap: $3.01 billion
  • Outstanding Shares: 54,181,000
Average Prices:
  • 50 Day Moving Avg: $54.48
  • 200 Day Moving Avg: $53.91
  • 52 Week Range: $40.65 - $61.10
  • Trailing P/E Ratio: 33.52
  • Foreward P/E Ratio: 17.69
  • P/E Growth: 1.16
Sales & Book Value:
  • Annual Revenue: $1.03 billion
  • Price / Sales: 2.92
  • Book Value: $6.52 per share
  • Price / Book: 8.52
  • EBITDA: $226.74 million
  • Net Margins: 5.69%
  • Return on Equity: 40.69%
  • Return on Assets: 9.87%
  • Debt-to-Equity Ratio: 1.27%
  • Current Ratio: 1.15%
  • Quick Ratio: 1.15%
  • Average Volume: 780,548 shs.
  • Beta: 1.34
  • Short Ratio: 4.84

Frequently Asked Questions for INC Research Holdings (NASDAQ:INCR)

What is INC Research Holdings' stock symbol?

INC Research Holdings trades on the NASDAQ under the ticker symbol "INCR."

How were INC Research Holdings' earnings last quarter?

INC Research Holdings, Inc. (NASDAQ:INCR) announced its quarterly earnings data on Thursday, July, 27th. The company reported $0.64 EPS for the quarter, hitting the Zacks' consensus estimate of $0.64. The firm earned $258.10 million during the quarter, compared to analyst estimates of $256.76 million. INC Research Holdings had a return on equity of 40.69% and a net margin of 5.69%. The company's revenue was down .3% on a year-over-year basis. During the same period last year, the company earned $0.61 earnings per share. View INC Research Holdings' Earnings History.

When will INC Research Holdings make its next earnings announcement?

INC Research Holdings is scheduled to release their next quarterly earnings announcement on Monday, October, 30th 2017. View Earnings Estimates for INC Research Holdings.

Where is INC Research Holdings' stock going? Where will INC Research Holdings' stock price be in 2017?

10 brokerages have issued 12-month target prices for INC Research Holdings' stock. Their predictions range from $57.00 to $69.00. On average, they anticipate INC Research Holdings' share price to reach $65.00 in the next year. View Analyst Ratings for INC Research Holdings.

Who are some of INC Research Holdings' key competitors?

Who are INC Research Holdings' key executives?

INC Research Holdings' management team includes the folowing people:

  • Michael A. Bell, Executive Chairman of the Board, President - Commercial Division
  • Alistair Macdonald, Chief Executive Officer, Director
  • Gregory S. Rush, Chief Financial Officer, Executive Vice President
  • Christopher L. Gaenzle, Chief Administrative Officer, General Counsel, Secretary
  • David York Norton, Non-Executive Independent Chairman of the Board
  • Todd Abbrecht, Director
  • Tom Allen, Director
  • Joshua Nelson, Director
  • Robert W. Breckon, Independent Director

How do I buy INC Research Holdings stock?

Shares of INC Research Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is INC Research Holdings' stock price today?

One share of INC Research Holdings stock can currently be purchased for approximately $55.55.

MarketBeat Community Rating for INC Research Holdings (NASDAQ INCR)
Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  169 (Vote Outperform)
Underperform Votes:  124 (Vote Underperform)
Total Votes:  293
MarketBeat's community ratings are surveys of what our community members think about INC Research Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for INC Research Holdings (NASDAQ:INCR) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 4 Hold Ratings, 6 Buy Ratings
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $65.00 (17.01% upside)
Consensus Price Target History for INC Research Holdings (NASDAQ:INCR)
Price Target History for INC Research Holdings (NASDAQ:INCR)
Analysts' Ratings History for INC Research Holdings (NASDAQ:INCR)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/11/2017Credit Suisse GroupInitiated CoverageOutperform$68.00N/AView Rating Details
10/9/2017Jefferies Group LLCUpgradeHold -> Buy$62.50 -> $69.00N/AView Rating Details
10/9/2017Robert W. BairdReiterated RatingBuy$67.00N/AView Rating Details
9/21/2017MizuhoInitiated CoverageNeutral$57.00LowView Rating Details
8/7/2017Goldman Sachs Group, Inc. (The)Reiterated RatingBuy -> Buy$65.00LowView Rating Details
6/20/2017William BlairDowngradeOutperform -> Market PerformHighView Rating Details
6/5/2017KeyCorpUpgradeSector Weight -> Overweight$68.00LowView Rating Details
5/31/2017SunTrust Banks, Inc.UpgradeHold -> Buy$48.00 -> $67.00MediumView Rating Details
5/3/2017Wells Fargo & CompanyDowngradeOutperform -> Market PerformHighView Rating Details
12/19/2016First AnalysisInitiated CoverageEqual -> Equal Weight$59.00N/AView Rating Details
4/18/2016Avondale PartnersBoost Price TargetMarket Perform$39.00 -> $47.00N/AView Rating Details
3/24/2016J P Morgan Chase & CoInitiated CoverageOverweight$47.00N/AView Rating Details
(Data available from 10/19/2015 forward)


Earnings History for INC Research Holdings (NASDAQ:INCR)
Earnings by Quarter for INC Research Holdings (NASDAQ:INCR)
Earnings History by Quarter for INC Research Holdings (NASDAQ INCR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/30/2017$0.68N/AView Earnings Details
7/27/2017Q2 2017$0.64$0.64$256.76 million$258.10 millionViewN/AView Earnings Details
5/10/2017Q1 2017$0.55$0.60$250.76 million$252.10 millionViewN/AView Earnings Details
2/28/2017Q4 2016$0.67$0.67$269.00 million$263.00 millionViewListenView Earnings Details
10/31/2016Q316$0.59$0.64$259.89 million$259.56 millionViewListenView Earnings Details
7/27/2016Q216$0.58$0.61$252.39 million$258.80 millionViewListenView Earnings Details
5/2/2016Q116$0.53$0.58$237.78 million$249.00 millionViewListenView Earnings Details
2/25/2016Q415$0.49$0.54$239.31 million$241.40 millionViewListenView Earnings Details
10/29/2015Q3$0.44$0.58$230.60 million$234.50 millionViewListenView Earnings Details
7/30/2015Q215$0.34$0.47$219.08 million$227.40 millionViewListenView Earnings Details
4/27/2015Q115$0.26$0.41$211.20 million$308.90 millionViewListenView Earnings Details
2/24/2015Q414$0.21$0.24$207.88 million$213.70 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for INC Research Holdings (NASDAQ:INCR)
2017 EPS Consensus Estimate: $2.54
2018 EPS Consensus Estimate: $2.79
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.56$0.64$0.61
Q2 20173$0.56$0.64$0.60
Q3 20174$0.57$0.65$0.62
Q4 20175$0.65$0.75$0.71
Q1 20181$0.61$0.61$0.61
Q2 20182$0.65$0.72$0.69
Q3 20181$0.72$0.72$0.72
Q4 20181$0.77$0.77$0.77
(Data provided by Zacks Investment Research)


Dividend History for INC Research Holdings (NASDAQ:INCR)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for INC Research Holdings (NASDAQ:INCR)
Insider Ownership Percentage: 0.24%
Institutional Ownership Percentage: 54.57%
Insider Trades by Quarter for INC Research Holdings (NASDAQ:INCR)
Institutional Ownership by Quarter for INC Research Holdings (NASDAQ:INCR)
Insider Trades by Quarter for INC Research Holdings (NASDAQ:INCR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/18/2017Alistair MacdonaldCEOSell2,348$54.60$128,200.80View SEC Filing  
9/18/2017Christopher L GaenzleCAOSell4,682$54.56$255,449.92View SEC Filing  
9/18/2017Gregory S RushCFOSell9,703$54.48$528,619.44View SEC Filing  
9/1/2017Christopher L GaenzleCAOSell42,601$58.67$2,499,400.67View SEC Filing  
9/1/2017Gregory S RushCFOSell88,739$58.99$5,234,713.61View SEC Filing  
8/30/2017Gregory S RushCFOSell41,420$58.26$2,413,129.20View SEC Filing  
8/17/2017Alistair MacdonaldCEOSell8,828$55.65$491,278.20View SEC Filing  
7/3/2017Alistair MacdonaldCEOSell10,555$58.38$616,200.90View SEC Filing  
6/30/2017Christopher L GaenzleCAOSell6,873$58.32$400,833.36View SEC Filing  
5/1/2017Alistair MacdonaldCEOSell9,467$45.00$426,015.00View SEC Filing  
4/3/2017Christopher L GaenzleCAOSell4,733$45.70$216,298.10View SEC Filing  
3/3/2017Alistair MacdonaldCEOSell8,828$45.00$397,260.00View SEC Filing  
1/20/2017Alistair MacdonaldCEOSell1,375$50.50$69,437.50View SEC Filing  
1/20/2017Christopher L GaenzleCAOSell1,186$50.09$59,406.74View SEC Filing  
1/19/2017Gregory S RushVPSell2,907$50.57$147,006.99View SEC Filing  
1/5/2017Alistair MacdonaldCEOSell14,840$52.19$774,499.60View SEC Filing  
9/30/2016Gregory S RushVPSell35,503$44.70$1,586,984.10View SEC Filing  
9/27/2016D. Jamie MacdonaldCEOSell53,970$44.30$2,390,871.00View SEC Filing  
9/26/2016Robert W BreckonDirectorSell12,197$44.16$538,619.52View SEC Filing  
9/19/2016David F BurgstahlerDirectorBuy1,000$43.19$43,190.00View SEC Filing  
9/14/2016Christopher L GaenzleCAOSell4,734$43.14$204,224.76View SEC Filing  
8/17/2016Alistair MacdonaldCOOSell8,828$43.80$386,666.40View SEC Filing  
8/4/2016Avista Capital Partners Ii Gp,Major ShareholderSell2,554,409$42.06$107,438,442.54View SEC Filing  
8/4/2016Teachers Pension Plan OntarioDirectorSell2,445,591$42.06$102,861,557.46View SEC Filing  
8/2/2016D. Jamie MacdonaldCEOSell31,279$43.00$1,344,997.00View SEC Filing  
8/1/2016Robert W BreckonDirectorSell108$42.00$4,536.00View SEC Filing  
7/28/2016Gregory S RushVPSell4,066$45.23$183,905.18View SEC Filing  
7/20/2016D. Jamie MacdonaldCEOSell100,593$43.00$4,325,499.00View SEC Filing  
7/15/2016Gregory S RushCFOSell5,917$41.50$245,555.50View SEC Filing  
7/11/2016Alistair MacdonaldCOOSell9,468$40.19$380,518.92View SEC Filing  
7/11/2016Christopher L GaenzleCAOSell21,918$40.20$881,103.60View SEC Filing  
7/1/2016Gregory S RushCFOSell1,358$37.97$51,563.26View SEC Filing  
7/1/2016Robert W BreckonDirectorSell421$37.97$15,985.37View SEC Filing  
6/15/2016Christopher L GaenzleCAOSell7,702$40.14$309,158.28View SEC Filing  
6/6/2016Michael GibertiniInsiderSell213,966$43.11$9,224,074.26View SEC Filing  
6/2/2016Robert W BreckonDirectorSell11,691$43.53$508,909.23View SEC Filing  
5/6/2016Avista Capital Partners Ii Gp,Major ShareholderSell4,087,054$45.12$184,407,876.48View SEC Filing  
5/6/2016Teachers Pension Plan OntarioDirectorSell3,912,946$45.12$176,552,123.52View SEC Filing  
4/18/2016James T OgleDirectorSell114,806$50.00$5,740,300.00View SEC Filing  
4/12/2016D. Jamie MacdonaldCEOSell94,675$48.00$4,544,400.00View SEC Filing  
4/1/2016Michael GibertiniInsiderSell9,000$40.78$367,020.00View SEC Filing  
3/1/2016Michael GibertiniInsiderSell9,000$39.85$358,650.00View SEC Filing  
2/4/2016Robert W. BreckonDirectorSell3,882$40.03$155,396.46View SEC Filing  
2/1/2016Gregory S. RushCFOSell17,752$40.27$714,873.04View SEC Filing  
2/1/2016Michael GibertiniinsiderSell9,000$40.57$365,130.00View SEC Filing  
1/4/2016Michael GibertiniinsiderSell9,000$46.83$421,470.00View SEC Filing  
12/31/2015Alistair MacdonaldCOOSell159,599$47.46$7,574,568.54View SEC Filing  
12/31/2015Christopher L. GaenzleCAOSell9,468$48.18$456,168.24View SEC Filing  
12/31/2015Gregory S. RushCFOSell35,503$48.17$1,710,179.51View SEC Filing  
12/29/2015James T. OgleDirectorSell9,717$50.06$486,433.02View SEC Filing  
12/8/2015Christopher L. GaenzleCAOSell25,185$41.78$1,052,229.30View SEC Filing  
12/8/2015Gregory S. RushCFOSell81,035$45.13$3,657,109.55View SEC Filing  
12/7/2015Alistair MacdonaldCOOSell42,959$44.63$1,917,260.17View SEC Filing  
12/7/2015Avista Capital Partners Ii Gp,Major ShareholderSell4,597,937$45.00$206,907,165.00View SEC Filing  
12/7/2015Teachers Pension Plan OntarioDirectorSell4,402,063$45.00$198,092,835.00View SEC Filing  
12/1/2015Michael GibertiniinsiderSell9,000$46.52$418,680.00View SEC Filing  
11/2/2015Michael GibertiniinsiderSell9,000$41.70$375,300.00View SEC Filing  
9/28/2015Alistair MacdonaldCOOSell44,522$39.93$1,777,763.46View SEC Filing  
9/14/2015Gregory S. RushCFOSell32,426$45.06$1,461,115.56View SEC Filing  
8/31/2015Christopher L. GaenzleCAOSell17,421$41.16$717,048.36View SEC Filing  
8/31/2015James T OgleDirectorSell55,000$41.12$2,261,600.00View SEC Filing  
8/17/2015Avista Capital Partners Ii Gp,Major ShareholderSell4,029,168$44.00$177,283,392.00View SEC Filing  
8/17/2015Teachers Pension Plan OntarioDirectorSell3,857,525$44.00$169,731,100.00View SEC Filing  
8/12/2015D. Jamie MacdonaldCEOSell57,021$44.00$2,508,924.00View SEC Filing  
8/12/2015Robert W BreckonDirectorSell8,381$44.00$368,764.00View SEC Filing  
5/14/2015Avista Capital Partners Ii Gp,Major ShareholderSell6,599,761$29.68$195,880,906.48View SEC Filing  
5/14/2015Teachers Pension Plan OntarioDirectorSell6,318,607$29.68$187,536,255.76View SEC Filing  
5/7/2015Gregory S RushCFOSell12,455$29.68$369,664.40View SEC Filing  
5/7/2015Michael GibertiniInsiderSell50,000$29.68$1,484,000.00View SEC Filing  
5/7/2015Robert W BreckonDirectorSell8,226$29.68$244,147.68View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for INC Research Holdings (NASDAQ:INCR)
Latest Headlines for INC Research Holdings (NASDAQ:INCR)
DateHeadline logoINC Research Holdings, Inc. (INCR) Given Average Rating of "Buy" by Brokerages - October 19 at 1:00 AM logoINC Research Holdings, Inc. (INCR) Now Covered by Credit Suisse Group - October 15 at 10:20 PM logoQ3 2017 Earnings Estimate for INC Research Holdings, Inc. Issued By Jefferies Group (INCR) - October 11 at 6:34 AM logoINC Research Holdings, Inc. breached its 50 day moving average in a Bullish Manner : INCR-US : October 10, 2017 - October 11 at 5:19 AM logoThe INC Research Pullback Creates A Compelling Entry Point - Benzinga - October 10 at 7:16 PM logoJefferies Upgrades INC Research Holdings (INCR) to Buy - - October 9 at 7:54 PM logoThe INC Research Pullback Creates A Compelling Entry Point - October 9 at 7:54 PM logoINC Research Holdings (INCR) vs. Idera Pharmaceuticals (IDRA) Head to Head Comparison - October 4 at 12:24 AM logoINC Research Holdings, Inc. (INCR) Expected to Post Quarterly Sales of $586.58 Million - October 3 at 1:18 PM logoINC Research Holdings, Inc. (INCR) Expected to Post Earnings of $0.62 Per Share - October 1 at 4:30 AM logoINC Research Holdings, Inc. (INCR) Receives Average Rating of "Hold" from Brokerages - September 23 at 11:10 PM logoINC Research Holdings, Inc. (INCR) Research Coverage Started at Mizuho - September 21 at 10:02 AM logoAlistair Macdonald Sells 2,348 Shares of INC Research Holdings, Inc. (INCR) Stock - September 19 at 8:08 PM logoINC Research Holdings, Inc. (INCR) CAO Christopher L. Gaenzle Sells 4,682 Shares - September 19 at 7:42 PM logoInsider Selling: INC Research Holdings, Inc. (INCR) CFO Sells 9,703 Shares of Stock - September 19 at 7:40 PM logo$586.58 Million in Sales Expected for INC Research Holdings, Inc. (INCR) This Quarter - September 14 at 8:20 AM logoStocks Generating Improved Relative Strength: IN Cresearch - September 12 at 1:33 AM logoINC Research Holdings (INCR) Presents At Baird's 2017 Global Healthcare Conference - Slideshow - September 8 at 11:16 PM logoINC Research Holdings, Inc. breached its 50 day moving average in a Bearish Manner : INCR-US : September 8, 2017 - September 8 at 11:16 PM logoINC Research Holdings (INCR) Presents At Wells Fargo Healthcare Conference - Slideshow - September 7 at 8:07 PM logoGregory S. Rush Sells 88,739 Shares of INC Research Holdings, Inc. (INCR) Stock - September 5 at 10:26 PM logoInsider Selling: INC Research Holdings, Inc. (INCR) CAO Sells 42,601 Shares of Stock - September 5 at 7:23 PM logoGregory S. Rush Sells 41,420 Shares of INC Research Holdings, Inc. (INCR) Stock - September 1 at 7:22 PM logoIN Cresearch Sees RS Rating Improve To 73 - August 30 at 1:28 AM logoINC Research Holdings, Inc. – Value Analysis (NASDAQ:INCR) : August 30, 2017 - August 30 at 1:28 AM logoINC Research Holdings, Inc. (INCR) Given Consensus Rating of "Hold" by Analysts - August 29 at 11:08 PM logo Brokerages Anticipate INC Research Holdings, Inc. (INCR) to Announce $0.62 Earnings Per Share - August 24 at 10:24 PM logoINC Research Holdings, Inc. breached its 50 day moving average in a Bullish Manner : INCR-US : August 23, 2017 - August 24 at 7:55 AM logoPortola Pharmaceuticals (PTLA) and INC Research Holdings (INCR) Head to Head Contrast - August 24 at 4:08 AM logoINC Research Holdings, Inc. (INCR) CEO Alistair Macdonald Sells 8,828 Shares - August 21 at 10:20 AM logoContrasting Arena Pharmaceuticals (ARNA) and INC Research Holdings (INCR) - August 18 at 8:10 PM logoSee what the IHS Markit Score report has to say about INC Research Holdings Inc. - August 14 at 10:36 PM logoinVentiv Group Holdings, Inc. -- Moody's downgrades INC Research to Ba3; outlook stable - August 11 at 11:17 PM logoETFs with exposure to INC Research Holdings, Inc. : August 11, 2017 - August 11 at 11:17 PM logoSee How INC Research Holdings Ranks Among Analysts' Top Picks With Strong Buyback Activity - August 11 at 3:59 AM logoINC Research Holdings, Inc. (NASDAQ:INCR) Given Consensus Rating of "Hold" by Analysts - August 4 at 10:38 PM logoINC Research and inVentiv Health Announce Successful Completion of Merger - August 1 at 3:27 PM logoDone deal: INC Research, inVentiv Health complete merger - August 1 at 3:27 PM logoFaruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against INC Research Holdings, Inc. - July 31 at 7:16 PM logoBrokers Offer Predictions for INC Research Holdings, Inc.'s Q2 2018 Earnings (INCR) - July 31 at 8:56 AM logoJefferies Group LLC Reaffirms Hold Rating for INC Research Holdings, Inc. (INCR) - July 30 at 11:38 AM logoINC Research Holdings, Inc. :INCR-US: Earnings Analysis: Q2, 2017 By the Numbers : July 28, 2017 - July 28 at 11:15 PM logoINC Research Holdings, Inc. (NASDAQ:INCR) Posts Quarterly Earnings Results, Meets Expectations - July 28 at 12:20 AM logoINC Research Reports Second Quarter 2017 Results - July 27 at 10:37 PM logoEdited Transcript of INCR earnings conference call or presentation 27-Jul-17 12:00pm GMT - July 27 at 10:37 PM logoINC Research meets 2Q profit forecasts - July 27 at 10:37 PM logo$257.67 Million in Sales Expected for INC Research Holdings, Inc. (NASDAQ:INCR) This Quarter - July 19 at 3:46 PM logoComparing INC Research Holdings (INCR) & Nektar Therapeutics (NKTR) - July 16 at 4:24 PM logoINC Research Holdings, Inc. breached its 50 day moving average in a Bearish Manner : INCR-US : July 14, 2017 - July 15 at 2:15 AM logoStull, Stull & Brody Announces Class Action Suit on Behalf of Shareholders of INC Research Holdings Inc. (NASDAQ: INCR) - July 14 at 3:51 AM



INC Research Holdings (INCR) Chart for Thursday, October, 19, 2017

This page was last updated on 10/19/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.